drugset / Trial / NCT00101738
Freedom Study: Myfortic in Kidney Transplant Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the study is to evaluate that 3 immunosuppressant regimens will have comparable kidney function results in kidney transplant patients.
Timeline
- Start
- 2003-03
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mycophenolic acid | Small molecule | — | — |
Indications
No indication recorded.